Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye

Clinical trial NCT01217398 · UNKNOWN

Trial details

NCT number: NCT01217398
Sponsor: Institut Curie
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Intraocular Melanoma

Start date: 2009-10-01
Primary completion: 2012-10-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.